FIGURE

Fig. 3

ID

ZDB-FIG-250610-9

Publication

Gundersen et al., 2025 - Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

DRV formulations demonstrate dose-dependent cytotoxicity towards AML and normal cell lines after various incubation times. The AML cell lines MOLM-13, OCI-AML3, and MV4–11, and the NRK cell line, were measured for viability after incubation with various concentrations of either empty dehydration-rehydration vesicles (DRV), free chlorpromazine (CPZ), CPZ-loaded DRV, or DRV loaded with different cyclodextrin (CD)/CPZ-complexes. Cells were either incubated for 24 or 72 h. The results are shown as viability relative to untreated cells as measured by the metabolic conversion of the WST-1 reagent and represent the mean ± SD from 2 to 5 wells obtained from two separate experiments.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Carbohydr. Polym.